share_log

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burnett Patrick

Arcutis Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Burnett Patrick

Arcutis Biotherapeutics | 4:持股变动声明-高管 Burnett Patrick
美股SEC公告 ·  11/06 05:51

Moomoo AI 已提取核心信息

Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of 15,441 shares of common stock on November 4, 2024. The transaction was executed in the open market at a price of $8.6842 per share, resulting in a total sale value of approximately $134,092.73. Following the sale, Burnett's direct holdings in the company amount to 179,418 shares of common stock.
Patrick Burnett, associated with Arcutis Biotherapeutics, Inc. [ARQT], completed a sale of 15,441 shares of common stock on November 4, 2024. The transaction was executed in the open market at a price of $8.6842 per share, resulting in a total sale value of approximately $134,092.73. Following the sale, Burnett's direct holdings in the company amount to 179,418 shares of common stock.
Patrick Burnett,与Arcutis Biotherapeutics,Inc. [ARQT]有关,于2024年11月4日完成了对15441股普通股的出售。该交易以每股8.6842美元的价格在公开市场上执行,结果约为134,092.73美元的总销售价值。在此次出售之后,Burnett在公司的直接持股数量为179,418股普通股。
Patrick Burnett,与Arcutis Biotherapeutics,Inc. [ARQT]有关,于2024年11月4日完成了对15441股普通股的出售。该交易以每股8.6842美元的价格在公开市场上执行,结果约为134,092.73美元的总销售价值。在此次出售之后,Burnett在公司的直接持股数量为179,418股普通股。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息